About us
A three-level comprehensive hospital integrating medical treatment, teaching, scientific research, and prevention, it is one of the 120 emergency network hospitals in Guangzhou, the first batch of internet hospitals in Guangdong Province, designated hospitals for medical insurance/work-related injury/maternity insurance and public medical linked hospitals in Guangzhou, and designated hospitals for direct settlement of medical insurance in different regions and across provinces in Guangdong Province. It is listed as a key livelihood project by the Guangzhou Municipal Government.
Disease classification
Live up to our youth, unite and strive to build the hospital into an innovative comprehensive hospital that emphasizes both Chinese and Western medicine, and has influence both domestically and internationally
Urinary system tumors
Gastric cancer
Breast cancer
Cervical carcinoma
Ovarian cancer
Uterine cancer
Prostatic cancer
Respiratory system tumors
lung cancer
Throat cancer
Nasopharyngeal carcinoma
Tracheal tumor
Tumor of the surface blood system
Lymphoma
Skin cancer
Melanoma
Multiple myeloma
Digestive system tumors
liver cancer
Gastric cancer
Rectal cancer
Pancreatic cancer
Esophageal cancer
Colon cancer
Other malignant tumors
Thyroid cancer
Cancer in the bones
Glioma
Osteosarcoma
Other tumors
Four major platforms
Accurate detection platform
Imaging examination platform
Tumor radiotherapy platform
Tumor comprehensive treatment platform
Accurate detection platform
More than 20 gene testing packages based on WES and NGS technology can be carried out for tumor concomitant diagnosis and supplementary diagnosis. The inspection center can carry out more than 2600 various testing projects, and the laboratory has reached the ISO15189 standard and the US Cap quality standard.
Imaging examination platform
There are more than 10 imaging examination equipment, including the fourth generation PET-MR (with compass technology), 2 PET-CT, 3.0T magnetic resonance imaging, and the fourth generation dual source CT. All imaging examination results can complete the fusion of images, truly achieving accurate radiotherapy for multimodal biological target delineation.
Tumor radiotherapy platform
We have the Encore M6 artificial intelligence radiosurgery radioknife, Varian TrueBeam and Halcyon linear accelerator, TomoTherayH spiral tomotherapy, Varian HDR/LDR intracavitary brachytherapy equipment, gamma knife treatment system, and radiation particle implantation treatment system. We will soon carry out nuclear therapy projects such as 90% yttrium therapy for liver cancer, 89% strontium therapy for bone tumors, 131% iodine therapy for hyperthyroidism and thyroid cancer, and 32% phosphorus application therapy for skin diseases.
Tumor comprehensive treatment platform
We have Da Vinci surgical robots, Siemens and Philips DSA and composite operating rooms, blood tumor transplantation modules, nano knife (IRE) treatment systems, argon helium knife cryoablation treatment systems, ultrasound focused knife treatment systems, and acoustic photodynamic treatment systems.
